Is CASBF or GBDC a better dividend investment in 2026?

CASBF currently yields 51.81% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: CASBF offers higher current income.

What is the dividend yield difference between CASBF and GBDC?

CASBF has a forward dividend yield of 51.81% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 39.95 percentage points.

Home › Compare › CASBF vs GBDC

CASBF vs GBDC: Dividend Comparison 2026

CASBF yields 51.81% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GBDC wins by $20.82M in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

CASBF

● Live price

51.81%

Share price

$3.86

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.0K

Annual income

$7.71

Full CASBF calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — CASBF vs GBDC

📍 GBDC pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CASBF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CASBF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CASBF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CASBF

Annual income on $10K today (after 15% tax)

$4,404.15/yr

After 10yr DRIP, annual income (after tax)

$6.55/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, GBDC beats the other by $13,983,117.20/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CASBF + GBDC for your $10,000?

CASBF: 50%GBDC: 50%

100% GBDC50/50100% CASBF

Portfolio after 10yr

$10.44M

Annual income

$8,225,370.77/yr

Blended yield

78.79%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CASBF

No analyst data

Altman Z

2.6

Piotroski

4/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CASBF buys

GBDC buys

No recent congressional trades found for CASBF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCASBFGBDC

Forward yield	51.81% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	-50%	51.1% ✓
Portfolio after 10y	$30.0K ✓	$20.85M
Annual income after 10y	$7.71	$16,450,733.83 ✓
Total dividends collected	$6.0K	$20.43M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: CASBF vs GBDC ($10,000, DRIP)

Year	CASBF Portfolio	CASBF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1	$13,291	$2,590.67	$12,492	$1,791.70	+$799.00 → CASBF
2← crossover	$15,830	$1,608.96	$16,527	$3,160.58	$697.00 → GBDC
3	$17,834	$895.50	$23,588	$5,904.90	$5.8K → GBDC
4	$19,553	$471.42	$37,141	$11,901.65	$17.6K → GBDC
5	$21,164	$241.53	$66,205	$26,463.38	$45.0K → GBDC
6	$22,767	$122.16	$137,452	$66,612.65	$114.7K → GBDC
7	$24,422	$61.41	$342,372	$195,298.53	$317.9K → GBDC
8	$26,163	$30.78	$1,053,292	$686,954.33	$1.03M → GBDC
9	$28,010	$15.41	$4,111,439	$2,984,416.95	$4.08M → GBDC
10	$29,978	$7.71	$20,849,974	$16,450,733.83	$20.82M → GBDC

CASBF vs GBDC: Complete Analysis 2026

CASBF — Stock

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. In addition, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB015 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

Full CASBF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this CASBF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CASBF vs SCHD CASBF vs JEPI CASBF vs O CASBF vs KO CASBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.